Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI.
MRD
MRI
PET/CT
minimal residual disease
multiple myeloma
treatment response
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
10 Nov 2022
10 Nov 2022
Historique:
received:
14
10
2022
revised:
01
11
2022
accepted:
08
11
2022
entrez:
29
12
2022
pubmed:
30
12
2022
medline:
30
12
2022
Statut:
epublish
Résumé
Bone disease is among the defining characteristics of symptomatic Multiple Myeloma (MM). Imaging techniques such as fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) and magnetic resonance imaging (MRI) can identify plasma cell proliferation and quantify disease activity. This function renders these imaging tools as suitable not only for diagnosis, but also for the assessment of bone disease after treatment of MM patients. The aim of this article is to review FDG PET/CT and MRI and their applications, with a focus on their role in treatment response evaluation. MRI emerges as the technique with the highest sensitivity in lesions' detection and PET/CT as the technique with a major impact on prognosis. Their comparison yields different results concerning the best tool to evaluate treatment response. The inhomogeneity of the data suggests the need to address limitations related to these tools with the employment of new techniques and the potential for a complementary use of both PET/CT and MRI to refine the sensitivity and achieve the standards for minimal residual disease (MRD) evaluation.
Identifiants
pubmed: 36579605
pii: jpm12111885
doi: 10.3390/jpm12111885
pmc: PMC9696713
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Acad Radiol. 2018 Jul;25(7):904-914
pubmed: 29373210
AJR Am J Roentgenol. 2019 Oct;213(4):918-924
pubmed: 31216203
Skeletal Radiol. 2022 Jan;51(1):59-80
pubmed: 34363522
Clin Nucl Med. 2013 Feb;38(2):e74-9
pubmed: 23143049
J Pers Med. 2020 Sep 10;10(3):
pubmed: 32927719
Leuk Lymphoma. 1996 Jun;22(1-2):131-5
pubmed: 8724540
Ther Adv Hematol. 2021 Sep 30;12:20406207211030369
pubmed: 34616538
Skeletal Radiol. 2022 Jul 26;:
pubmed: 35881152
Br J Radiol. 2019 Mar;92(1095):20180768
pubmed: 30604631
Mol Imaging Biol. 2022 Oct;24(5):842-851
pubmed: 35501622
Blood. 2013 Mar 7;121(10):1819-23
pubmed: 23305732
Am J Hematol. 2022 Jul;97(7):877-884
pubmed: 35389534
Blood Cancer J. 2017 Dec 5;7(12):639
pubmed: 29209089
Jpn J Radiol. 2018 Jun;36(6):382-393
pubmed: 29671193
Lancet Oncol. 2019 Jun;20(6):e302-e312
pubmed: 31162104
World J Surg Oncol. 2007 Jun 20;5:68
pubmed: 17584499
Mayo Clin Proc. 2003 Jan;78(1):21-33
pubmed: 12528874
Oncotarget. 2017 Apr 11;8(15):25637-25649
pubmed: 27556189
J Clin Oncol. 2017 Sep 1;35(25):2911-2918
pubmed: 28686535
Am J Hematol. 2017 Aug;92(8):746-751
pubmed: 28383205
Br J Haematol. 2022 Aug;198(3):515-522
pubmed: 35582835
Front Oncol. 2022 Mar 04;12:780078
pubmed: 35311101
J Magn Reson Imaging. 1996 Mar-Apr;6(2):311-21
pubmed: 9132096
Radiology. 2014 Jun;271(3):785-94
pubmed: 24475858
J Nucl Med. 2015 Jan;56(1):63-9
pubmed: 25476536
Eur J Radiol. 2010 Dec;76(3):323-8
pubmed: 20381277
Leukemia. 2019 Jul;33(7):1713-1722
pubmed: 30573775
Radiol Med. 2019 Mar;124(3):218-233
pubmed: 30430385
Blood. 2017 Jul 6;130(1):30-34
pubmed: 28432222
Zhonghua Xue Ye Xue Za Zhi. 2017 Feb 14;38(2):129-133
pubmed: 28279037
Cancer. 2002 Sep 15;95(6):1334-45
pubmed: 12216103
Br J Haematol. 2018 Mar;180(6):831-839
pubmed: 29315478
Front Oncol. 2014 Sep 04;4:241
pubmed: 25237651
Ann Nucl Med. 2015 Apr;29(3):224-32
pubmed: 25421383
Clin Cancer Res. 2015 Oct 1;21(19):4384-90
pubmed: 26078390
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1995-2004
pubmed: 27121691
Cancer Imaging. 2020 Jan 30;20(1):14
pubmed: 32000858
Skeletal Radiol. 2022 Jul 9;:
pubmed: 35809098
Cancer. 2012 Mar 15;118(6):1574-84
pubmed: 21932386
PLoS One. 2013 Dec 23;8(12):e84840
pubmed: 24376850
Diagnostics (Basel). 2021 Apr 15;11(4):
pubmed: 33920809
J Clin Oncol. 2015 Feb 20;33(6):657-64
pubmed: 25605835
EJNMMI Res. 2018 Apr 10;8(1):28
pubmed: 29633046
Acad Radiol. 2015 Sep;22(9):1163-71
pubmed: 26182979
Blood. 2009 Sep 3;114(10):2068-76
pubmed: 19443657
J Nucl Med. 2014 May;55(5):749-52
pubmed: 24676754
Acad Radiol. 2010 Nov;17(11):1326-33
pubmed: 20817572
Leuk Lymphoma. 2016 Sep;57(9):2071-6
pubmed: 26726867
Br J Haematol. 2017 Jan;176(2):222-233
pubmed: 27766627
Rofo. 2019 Sep;191(9):805-816
pubmed: 31185511
Radiol Imaging Cancer. 2021 Sep;3(5):e210048
pubmed: 34559006
Front Oncol. 2022 Jul 07;12:934240
pubmed: 35875104
Radiographics. 2019 Jul-Aug;39(4):1077-1097
pubmed: 31283452
Skeletal Radiol. 2022 Jan;51(1):101-122
pubmed: 34523007
Br J Radiol. 2012 Dec;85(1020):e1198-203
pubmed: 23175485
Radiology. 2019 Apr;291(1):5-13
pubmed: 30806604
Magn Reson Med. 1988 Jul;7(3):346-51
pubmed: 3205150
Clin Nucl Med. 2019 Aug;44(8):620-624
pubmed: 31274607
Radiology. 2020 Jun;295(3):606-615
pubmed: 32255416
Exp Ther Med. 2021 Aug;22(2):827
pubmed: 34149873
Cent Nerv Syst Agents Med Chem. 2014;14(1):23-7
pubmed: 25134940
Eur Radiol. 2017 Dec;27(12):5325-5336
pubmed: 28656463
Crit Rev Oncol Hematol. 2018 Apr;124:66-72
pubmed: 29548488
Ann Oncol. 2021 Mar;32(3):309-322
pubmed: 33549387
Blood Adv. 2022 May 10;6(9):2763-2772
pubmed: 35235951
Am J Hematol. 2019 Oct;94(10):1132-1140
pubmed: 31334859
Blood Cancer J. 2017 Aug 25;7(8):e599
pubmed: 28841211
Am J Hematol. 2020 May;95(5):548-567
pubmed: 32212178
Am J Hematol. 2019 Aug;94(8):853-861
pubmed: 31074033
Blood Adv. 2021 Jul 13;5(13):2753-2759
pubmed: 34242392
AJR Am J Roentgenol. 2011 Jun;196(6):W790-5
pubmed: 21606271
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):537-546
pubmed: 31776631
Eur J Radiol. 2012 Dec;81(12):4013-8
pubmed: 22921683
J Clin Med. 2020 Oct 31;9(11):
pubmed: 33142671
Eur J Radiol. 2016 Feb;85(2):373-82
pubmed: 26781143
AJR Am J Roentgenol. 2017 Dec;209(6):W336-W349
pubmed: 28981354
Ann Nucl Med. 2021 Oct;35(10):1147-1156
pubmed: 34185263
AJR Am J Roentgenol. 2022 Apr;218(4):602-613
pubmed: 34704461
PLoS One. 2020 Feb 27;15(2):e0229607
pubmed: 32106239
Cancers (Basel). 2021 Apr 16;13(8):
pubmed: 33923781
Clin Radiol. 2017 Oct;72(10):850-857
pubmed: 28587715
Magn Reson Imaging. 2013 Oct;31(8):1285-91
pubmed: 23290477
Blood. 2011 Dec 1;118(23):5989-95
pubmed: 21900189
J Clin Oncol. 2021 Jan 10;39(2):116-125
pubmed: 33151787